| Product Code: ETC9398333 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 South Korea Basal Insulin (Long Acting Insulin) Market Overview | 
| 3.1 South Korea Country Macro Economic Indicators | 
| 3.2 South Korea Basal Insulin (Long Acting Insulin) Market Revenues & Volume, 2021 & 2031F | 
| 3.3 South Korea Basal Insulin (Long Acting Insulin) Market - Industry Life Cycle | 
| 3.4 South Korea Basal Insulin (Long Acting Insulin) Market - Porter's Five Forces | 
| 3.5 South Korea Basal Insulin (Long Acting Insulin) Market Revenues & Volume Share, By Products, 2021 & 2031F | 
| 4 South Korea Basal Insulin (Long Acting Insulin) Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.2.1 Increasing prevalence of diabetes in South Korea | 
| 4.2.2 Growing awareness about the benefits of long-acting insulin in diabetes management | 
| 4.2.3 Technological advancements in insulin delivery devices | 
| 4.3 Market Restraints | 
| 4.3.1 High cost associated with basal insulin treatment | 
| 4.3.2 Regulatory hurdles related to approval and reimbursement | 
| 4.3.3 Competition from alternative therapies such as oral anti-diabetic drugs | 
| 5 South Korea Basal Insulin (Long Acting Insulin) Market Trends | 
| 6 South Korea Basal Insulin (Long Acting Insulin) Market, By Types | 
| 6.1 South Korea Basal Insulin (Long Acting Insulin) Market, By Products | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 South Korea Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Products, 2021- 2031F | 
| 6.1.3 South Korea Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Lantus, 2021- 2031F | 
| 6.1.4 South Korea Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Levemir, 2021- 2031F | 
| 6.1.5 South Korea Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Tresiba, 2021- 2031F | 
| 6.1.6 South Korea Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Toujeo, 2021- 2031F | 
| 6.1.7 South Korea Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Basaglar, 2021- 2031F | 
| 7 South Korea Basal Insulin (Long Acting Insulin) Market Import-Export Trade Statistics | 
| 7.1 South Korea Basal Insulin (Long Acting Insulin) Market Export to Major Countries | 
| 7.2 South Korea Basal Insulin (Long Acting Insulin) Market Imports from Major Countries | 
| 8 South Korea Basal Insulin (Long Acting Insulin) Market Key Performance Indicators | 
| 8.1 Patient adherence rate to long-acting insulin therapy | 
| 8.2 Rate of adoption of new insulin delivery technologies | 
| 8.3 Number of clinical trials evaluating the efficacy of basal insulin in South Korea | 
| 9 South Korea Basal Insulin (Long Acting Insulin) Market - Opportunity Assessment | 
| 9.1 South Korea Basal Insulin (Long Acting Insulin) Market Opportunity Assessment, By Products, 2021 & 2031F | 
| 10 South Korea Basal Insulin (Long Acting Insulin) Market - Competitive Landscape | 
| 10.1 South Korea Basal Insulin (Long Acting Insulin) Market Revenue Share, By Companies, 2024 | 
| 10.2 South Korea Basal Insulin (Long Acting Insulin) Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |